Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A.P. Moller Holding is an active investment company and parent to the A.P. Moller Group, with assets under management of approximately USD 32 billion. It invests across diversified sectors including transport, logistics, finance, energy, infrastructure, and selected healthcare and medtech assets through its portfolio companies. It is not itself an operator or developer in life sciences, biotech, or pharma, and does not have a therapeutic pipeline or proprietary platform technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on A.P. Moller Holding.